- $1.47bn
- $3.96bn
- $4.18bn
- 80
- 97
- 77
- 98
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.35 | ||
| EV to EBITDA | 9.7 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 16.71% | ||
| Return on Equity | n/a | ||
| Operating Margin | 5.68% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 3,452.6 | 2,268.2 | 3,148 | 4,686.3 | 4,181 | 3,956.95 | 4,002.87 | 3.63% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Calumet, Inc. is engaged in manufacturing, formulating, and marketing a diversified slate of specialty branded products to customers in various consumer-facing and industrial markets. The Company’s division includes Specialty Products and Solutions, Performance Brands and Montana Renewables. The Specialty Products and Solutions division manufactures specialty oils, base oils, solvents, waxes, and esters. Its specialty oils brands include DRAKEOL, HYPERTECH, PAROL, PENPURE, Penreco, and petrolatums. Its base oils brands include CALICE, CALPAR, CALPRO, CALSOL, CALTAC, CALTRAN, CALVIS, and DFO. Its solvents include CALSIA, CALTANE, CALPRINT, CONOSOL, DRAKESOL, and MAGIESOL. Its waxe brands include CALUMET WAX and TitanWax. Its Performance Brands division formulates, blends and packages premium finished lubricants, chemicals, and engineered fuel products. Its performance brands include BEL-RAY, ROYAL PURPLE, and TRUFUEL. Montana Renewables manufactures sustainable aviation fuel (SAF).
Directors
- Address
- 1060 N Capitol Ave, Suite 6-401, INDIANAPOLIS, 46204-1044
- Web
- https://calumet.com/
- Phone
- +1 3173285660
- Auditors
- Ernst & Young LLP
Upcoming Events for CLMT
Similar to CLMT
APA (US)
NASDAQ Global Select Market
Berry (Bry)
NASDAQ Global Select Market
Chesapeake Energy
NASDAQ Global Select Market
Chord Energy
NASDAQ Global Select Market
Clean Energy Fuels
NASDAQ Global Select Market
FAQ
What is the Calumet share price?
As of Today at 20:14 UTC, shares in Calumet are trading at $17.16. This share price information is delayed by 15 minutes.
How has the Calumet share price performed this year?
Shares in Calumet last closed at $17.16 and the price had moved by -12.72% over the past 365 days. In terms of relative price strength the Calumet share price has underperformed the S&P500 Index by -30.96% over the past year.
What are the analyst and broker recommendations for Calumet?
The overall consensus recommendation for Calumet is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Calumet dividend yield?
Calumet does not currently pay a dividend.
Does Calumet pay a dividend?
Calumet does not currently pay a dividend.
When does Calumet next pay dividends?
Calumet does not currently pay a dividend.
How do I buy Calumet shares?
To buy shares in Calumet you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Calumet?
As of the previous close price of $17.16, shares in Calumet had a market capitalisation of $1.47bn.
Where are Calumet shares listed?
Here are the trading details for Calumet:
- Country of listing: United States
- Exchange: NSQ
- Ticker Symbol: CLMT
What kind of share is Calumet?
Based on an overall assessment of its quality, value and momentum Calumet is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Calumet share price forecast for 2024?
The analyst consensus target price for shares in Calumet is $21.63. That is 26.05% above the last closing price of $17.16.
Analysts covering Calumet currently have a consensus Earnings Per Share (EPS) forecast of -$1.62 for the next financial year.
Find out moreWhat is the trend in the Calumet share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Calumet. Over the past six months, its share price has outperformed the S&P500 Index by +10.26%.
As of the last closing price of $17.16, shares in Calumet were trading +7.54% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Calumet PE Ratio?
The Calumet PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $17.16.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Calumet?
Calumet's management team is headed by:
- Fred Fehsenfeld - CHM
- Stephen Mawer - CEO
- Louis Borgmann - CFO
- Bruce Fleming - EVP
- Scott Obermeier - EVP
- Vincent Donargo - CAO
- Paul Raymond - DRC
- Daniel Sajkowski - DRC
- Amy Schumacher - DRC
- Jennifer Straumins - DRC
- James Carter - IND
- Robert Funk - IND
- Daniel Sheets - IND